Our studies have also revealed that β-catenin and Dvl-2 are upregulated along with DACT1, and demonstrate that there is a trend toward poor survival in patients with tumors that have higher scores for DACT1 expression in colon adenocarcinomas [35]. The gene discussed is DVL2; the disease is colon adenocarcinoma.